JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 8 No. 7 529-541
© 1967 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herbert, V.
Right arrow Articles by Wasserman, L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herbert, V.
Right arrow Articles by Wasserman, L. R.

Coated Charcoal Assay of Plasma Iron Binding Capacity and Iron Using Radioisotope Dilution and Hemoglobin-Coated Charcoal1,2,

Victor Herbert3, Chester W. Gottlieb4, Kam-Seng Lau5, Norman R. Gevirtz6, Lena Sharney7 and Louis R. Wasserman8

New York, New York

ABSTRACT

Using radioisotope dilution, and hemoglobin-coated charcoal for batch separation, plasma iron may be measured. From 0.5 ml of plasma, native transfersin-bound iron is released at pH 5.8 (by adding 0.5 ml of pH 5.3 buffer to the plasma), following which 3 µg labeled iron is added. After subsequent addition of buffer to raise the pH to 7.4 and thus allow rebinding of a portion of the pool of radiodiluted iron by transferrin, iron-transferrin complex is separated from excess free iron by hemoglobin-coated charcoal and the plasma iron level computed by an appropriate formula. This method provides a model for the assay of similar constituents in biologic fluids, in which the binder for the agent is naturally present in the fluid under assay.

FOOTNOTES

1 This work was supported in part by Research Grants AM 01063, AM 09062, AM09564 from the National Institute of Arthritis and Metabolic Diseases of the USPHS, by the World Health Organization, and by the Albert A. List, Frederick Machlin and Anna Ruth Lowenberg Funds.

2 Presented in part at the Fifth Annual Meeting of the American Society for Clinical Nutrition, Atlantic City, New Jersey, May 1, 1965 (1).

3 Recipient of Career Scientist Award I-435 from the Health Research Council of the City of New York.

4 Current Address: Medical Research Laboratory, Clinical Investigations Branch, United States Army Edgewood Arsenal, Edgewood Arsenal, Maryland. Formerly, Research Assistant, The Department of Hematology, The Mount Sinai Hospital, New York.

5 Current Address: Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Formerly, Research Fellow of the World Health Organization at The Mount Sinai Hospital, New York.

6 Current Address: Department of Medicine, New York Medical College, New York. Formerly, Assistant Attending Hematologist, The Mount Sinai Hospital, New York.

7 Jointiy affiliated with The Mount Sinai Hospital of the City of New York and with the Department of Mathematics of C. W. Post College, Long Island University, Brookville, New York.

8 The Department of Hematology, The Mount Sinai Hospital and School of Medicine, New York City, N. Y.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1967 by the Society of Nuclear Medicine.